Allergan recalls textured breast implants worldwide
(Reuters) – Allergan Plc said on Wednesday it was recalling its Biocell textured breast implants and tissue expanders across markets, citing concerns over a rare form of cancer, after the…
Allergan’s add-on treatment for depression fails late-stage studies
FILE PHOTO: The Allergan logo is seen in this photo illustration November 23, 2015. To match special report USA-FDA/CASES REUTERS/Thomas White/Illustration/File Photo (Reuters) – Allergan Plc said on Wednesday its…
Allergan, Molecular Partners eye drug meets main goal in two studies
(Reuters) – Allergan Plc and Molecular Partners AG said on Thursday their treatment for neovascular age-related macular degeneration, a leading cause of vision loss among people over 65, met the…
Allergan plans sales of women’s health, infectious disease units
NEW YORK (Reuters) – Drugmaker Allergan Plc (AGN.N) plans to sell off its women’s health and infectious disease businesses as Chief Executive Brent Saunders works to end the steep slide…
Allergan migraine drug succeeds in second late-stage trial
NEW YORK (Reuters) – Allergan Plc on Friday announced positive results from a second Phase III trial for the 50 milligram dose of its drug for acute migraine, reproducing results…